GLP side-effects: allodynia or dysesthesia

joewood7825

New Member
Summary
A member on semaglutide, tirzepatide and retatrutide reports allodynia or dysesthesia at moderate doses and asks how to reduce it.
I have tried sema, tirz and reta, tritrating up on each one to be cautious of side effects. I have had no gastro intestinal problems whatsoever. However, in each case, when I reached a moderate dose I began to have sensation of allodynia or dysesthesia. This occured far below what most studies suggest is the optimal dose for weight loss. Is there any way to mitigate this side effect?
 
Joe, what you're describing is a known side effect of the whole GLP-1 class. The only proven fix is a lower dose. It rises with dose and it reverses, so aim for the highest dose you tolerate, not the dose the trials used.
Why:
  1. It's real and tied to dose. New Zealand's drug regulator now lists dysaesthesia, paraesthesia, hyperaesthesia, burning sensation, allodynia and sensitive skin for semaglutide, and dysesthesia for tirzepatide. In the high-dose semaglutide trials, dysesthesia hit 19-23% of people on 7.2 mg weekly versus 5-6% on 2.4 mg. Retatrutide shows the same pattern: 8.8% at 9 mg and 20.9% at 12 mg in TRIUMPH-4, versus 0.7% on placebo.
  2. It goes away. In a semaglutide case series, the two patients who stopped had full resolution, and one of the two who kept going resolved after 4 months. A 2025 report on semaglutide and tirzepatide found it dose dependent, resolving with discontinuation and sometimes on its own after several weeks.
You had it on all three drugs, so switching to another drug in this class probably won't help.
What I'd do:
  • Go back to the last dose that caused no symptoms and stay there. Lower doses still work: retatrutide 4 mg averaged 19.0% weight loss in TRIUMPH-1. Slower loss without nerve pain beats faster loss you can't live with.
  • Ask your doctor about splitting the weekly dose into two smaller shots to lower the peak level. Nobody has studied this for allodynia, so treat it as an experiment.
  • Rule out other things that irritate nerves during fast weight loss and low food intake: B12, vitamin D, thyroid, glucose/A1c and magnesium.
  • If symptoms continue even at a dose you otherwise tolerate, see your doctor. Nerve-pain drugs like pregabalin or duloxetine are options, but one published patient got GLP-1 allodynia while already on both.
Retatrutide is still investigational. It has no approval and no approved dosing.
To help further: what doses were you on with each drug when it started, where on your body do you feel it, and are you diabetic or on metformin?
More detail in our retatrutide guide: Retatrutide: Weight Loss, Dosing, Side Effects 2026
References:
Medsafe: GLP-1 receptor agonists and altered skin sensations (2026)
Ahern, Cureus 2025: Allodynia and dysesthesia with semaglutide and tirzepatide
Am J Case Rep 2026: Cutaneous allodynia with tirzepatide
 

ExcelMale Newsletter Signup

Free ExcelMale Downloads: men's health guides, eBooks and resources

Sponsors

Online statistics

Members online
3
Guests online
2,560
Total visitors
2,563

ExcelMale Newsletter Signup

Back
Top